T2 Biosystems Inc (FRA:3T2)
€ 4.06 -0.15 (-3.56%) Market Cap: 67.24 Mil Enterprise Value: 106.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q4 2018 T2 Biosystems Inc Earnings Call Transcript

Mar 07, 2019 / 09:30PM GMT
Release Date Price: €271 (-13.14%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the T2 Biosystems Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions)

It is now my pleasure to turn the call over to Zack Kubow of the W2O Group. Please go ahead, sir.

Zack Kubow

Thank you, operator, and good afternoon, everyone. Thanks for joining us for the T2 Biosystems Fourth Quarter and Full Year 2018 Financial Results Conference Call.

On the call to discuss the results and operational highlights for the quarter and year ended December 31, 2018, are President and CEO, John McDonough; and Chief Financial Officer, John Sprague. The executive team will open the call with prepared remarks, followed by a question-and-answer period.

I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products. Forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot